JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MLNX
1526
PUT
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $12.1M | ﹤0.01% |
100,000
| – | – |
2019 Q3
2 quarters
|
|
1527
Eagle Materials
EXP
$5.21B
| $12.1M | ﹤0.01% |
207,568
+124,669
| +150% | +$9.94M |
2013 Q2
27 quarters
|
|
1528
PUT
HCA Healthcare
HCA
$93.8B
| $12.1M | ﹤0.01% |
134,600
-75,100
| -36% | -$9.72M |
2017 Q2
11 quarters
|
|
1529
Ally Financial
ALLY
$11.5B
| $12.1M | ﹤0.01% |
836,557
-1,046,794
| -56% | -$27.5M |
2014 Q2
23 quarters
|
|
1530
Corning
GLW
$138B
| $12M | ﹤0.01% |
585,600
-160,458
| -22% | -$4.18M |
2013 Q2
27 quarters
|
|
1531
Lear
LEA
$6.02B
| $12M | ﹤0.01% |
147,981
+48,180
| +48% | +$5.55M |
2013 Q2
27 quarters
|
|
1532
TransAlta
TAC
$3.93B
| $12M | ﹤0.01% |
2,294,261
+620,439
| +37% | +$4.21M |
2014 Q3
22 quarters
|
|
1533
PUT
Merck
MRK
$344B
| $12M | ﹤0.01% |
163,698
-230,455
| -58% | -$18.1M |
2014 Q3
22 quarters
|
|
1534
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.27B
| $12M | ﹤0.01% |
448,356
-91,239
| -17% | -$2.87M |
2015 Q1
20 quarters
|
|
|
MASI
1535
DELISTED
Masimo
MASI
| $12M | ﹤0.01% |
67,756
-46,078
| -40% | -$7.9M |
2013 Q2
27 quarters
|
|
|
CCXX.U
1536
DELISTED
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
| $12M | ﹤0.01% |
+1,198,714
| New | +$12.2M |
2020 Q1
0 quarters
|
|
1537
Edgewell Personal Care
EPC
$1.21B
| $12M | ﹤0.01% |
496,998
+354,799
| +250% | +$10.6M |
2013 Q2
27 quarters
|
|
1538
Equitable Holdings
EQH
$14.6B
| $12M | ﹤0.01% |
827,370
+170,715
| +26% | +$3.73M |
2018 Q2
7 quarters
|
|
|
DOOR
1539
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $12M | ﹤0.01% |
251,932
+70,100
| +39% | +$4.96M |
2014 Q4
21 quarters
|
|
1540
The Ensign Group
ENSG
$10.1B
| $12M | ﹤0.01% |
317,810
-261,016
| -45% | -$11.4M |
2013 Q2
27 quarters
|
|
1541
WD-40
WDFC
$2.73B
| $11.9M | ﹤0.01% |
59,474
+23,716
| +66% | +$4.47M |
2013 Q2
27 quarters
|
|
1542
Arrowhead Research
ARWR
$8.87B
| $11.9M | ﹤0.01% |
413,937
-158,703
| -28% | -$6.4M |
2018 Q2
7 quarters
|
|
1543
Hope Bancorp
HOPE
$1.74B
| $11.9M | ﹤0.01% |
1,444,533
+126,739
| +10% | +$1.58M |
2013 Q2
27 quarters
|
|
|
CCRN
1544
DELISTED
Cross Country Healthcare
CCRN
| $11.8M | ﹤0.01% |
1,757,712
+150,927
| +9% | +$1.43M |
2013 Q2
27 quarters
|
|
1545
Invesco KBW Bank ETF
KBWB
$6.22B
| $11.7M | ﹤0.01% |
350,060
+221,087
| +171% | +$10.8M |
2017 Q2
11 quarters
|
|
1546
Tronox
TROX
$616M
| $11.7M | ﹤0.01% |
2,355,954
+1,960,523
| +496% | +$16.2M |
2015 Q3
18 quarters
|
|
1547
PUT
Qualcomm
QCOM
$196B
| $11.7M | ﹤0.01% |
172,600
-297,100
| -63% | -$24.4M |
2017 Q1
12 quarters
|
|
1548
Lamar Advertising Co
LAMR
$14.6B
| $11.7M | ﹤0.01% |
227,278
-9,373
| -4% | -$755K |
2013 Q2
27 quarters
|
|
1549
PUT
Wells Fargo
WFC
$246B
| $11.6M | ﹤0.01% |
405,600
-362,500
| -47% | -$15.4M |
2014 Q2
23 quarters
|
|
|
WORK
1550
PUT
DELISTED
Slack Technologies, Inc.
WORK
| $11.6M | ﹤0.01% |
431,900
| – | – |
2019 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.